Compare CTS & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTS | CRON |
|---|---|---|
| Founded | 1896 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 961.2M |
| IPO Year | N/A | N/A |
| Metric | CTS | CRON |
|---|---|---|
| Price | $44.74 | $2.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 184.4K | ★ 1.9M |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | ★ 0.36% | N/A |
| EPS Growth | ★ 3.07 | N/A |
| EPS | ★ 1.98 | 0.09 |
| Revenue | ★ $531,522,000.00 | $132,357,000.00 |
| Revenue This Year | $5.73 | $19.67 |
| Revenue Next Year | $4.00 | $30.56 |
| P/E Ratio | ★ $22.55 | $29.63 |
| Revenue Growth | 3.61 | ★ 19.00 |
| 52 Week Low | $34.02 | $1.60 |
| 52 Week High | $57.49 | $3.16 |
| Indicator | CTS | CRON |
|---|---|---|
| Relative Strength Index (RSI) | 59.56 | 71.81 |
| Support Level | $42.68 | $2.40 |
| Resistance Level | $45.65 | $2.55 |
| Average True Range (ATR) | 1.39 | 0.12 |
| MACD | 0.12 | 0.03 |
| Stochastic Oscillator | 79.09 | 83.46 |
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.